

"AI powered medical imaging transforming stroke care and diagnosis worldwide"
Brainomix specialises in AI powered imaging biomarkers enabling precision medicine for critical healthcare decisions. As a University of Oxford spinout, the company developed the Brainomix 360 Stroke platform, the most comprehensive stroke imaging solution available, which automates validated biomarkers to improve diagnosis and treatment. Trusted by healthcare systems in over 30 countries, the technology processes a scan every three minutes and delivers results in 60 seconds. Beyond stroke, Brainomix is expanding into lung disease and cancer, applying AI imaging to enhance clinical trials and patient care. The company transforms ordinary scans into extraordinary clinical insights, improving outcomes where speed and accuracy save lives.


77
Team Members
2010
Founded
Digital Health
Sector
Hybrid
Work Environment
A world where every patient receives expert level medical imaging analysis instantly, regardless of location, eliminating diagnostic delays and ensuring equitable access to life saving precision medicine globally
At Brainomix, our mission is to harness artificial intelligence to transform patient care and improve outcomes by automating validated imaging biomarkers that enable precision medicine for better treatment decisions.